You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ovarian papillary serous carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

Completed
  • Serous Ovarian Carcinoma
  • Low Grade Serous Ovarian Carcinoma
  • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
  • Lyon, France
    Hospices civils de Lyon
Feb 14, 2023

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Endometrial Cancer, Papillary Serous Endometrial Carcinoma, Uterine Serous Carcinoma Trial in United States (Niraparib)

Recruiting
  • Endometrial Cancer
  • +4 more
  • New Brunswick, New Jersey
  • +4 more
Mar 17, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

Recruiting
  • Carcinoma, Ovarian Epithelial
  • Low Grade Serous Adenocarcinoma of Ovary
  • Letrozole tablets
  • carboplatin AUC 5 and paclitaxel 175 mg/m2
  • Brescia, BS, Italy
  • +1 more
Oct 26, 2022

Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

Completed
Has Results
  • Ovarian Endometrioid Adenocarcinoma
  • +8 more
  • Jacksonville, Florida
  • +1 more
Sep 28, 2020

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

Not yet recruiting
  • High Grade Serous Ovarian Cancer
  • Blood sample and tissue sample
  • Montpellier, France
    NOUGARET Stephanie
Oct 10, 2023

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    Recurrent Endometrial Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Aurora

    Active, not recruiting
    • Recurrent Endometrial Serous Adenocarcinoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Aurora, Colorado
      University of Colorado Hospital
    May 24, 2022

    Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Sunnybrook Research Institute
    Jul 18, 2023

    Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

    Not yet recruiting
    • Fallopian Tube Carcinosarcoma
    • +14 more
    • Biopsy
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 28, 2023

    Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

    Not yet recruiting
    • Serous Ovarian Cancer
    • Advanced Ovarian Cancer
    • (no location specified)
    Sep 20, 2023

    Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Cetntre
    Sep 25, 2023

    Gynecologic Cancer, Ovarian Cancer, High Grade Serous Carcinoma Trial in Ljubljana (Carboplatin)

    Recruiting
    • Gynecologic Cancer
    • +3 more
    • Ljubljana, Slovenia
    • +1 more
    Aug 6, 2022

    Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

    Terminated
    • Ovarian Cancer
    • +21 more
    • Exercise Counseling
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 6, 2022

    Patients With Low Grade Ovarian or Peritoneal Tumors

    Recruiting
    • Low Grade Ovarian Serous Adenocarcinoma
    • +5 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Ovarian High Grade Serous Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma Trial in Atlanta (Atovaquone, Biopsy, Computed

    Not yet recruiting
    • Ovarian High Grade Serous Adenocarcinoma
    • Platinum-Resistant Ovarian Carcinoma
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 11, 2023

    Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)

    Not yet recruiting
    • Ovarian Cancer
    • Serous Ovarian Cancer
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute
    Apr 17, 2022

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022